Tripura Merger Agreement

ManTech Stockholders Approve Acquisition by Carlyle

Retrieved on: 
Wednesday, September 7, 2022
Tripura Merger Agreement, King & Spalding, Government, NASDAQ, LLP, Solution, Person, Mantech, Special, U.S. Securities and Exchange Commission, GLOBE, CG, Nasdaq, Company, Latham & Watkins, Communication, Failure, Data collection, Goldman Sachs, Risk, Forward-looking statement, Holding company, Financial adviser, Bank

As previously announced, under the terms of the transaction, ManTech stockholders will receive $96.00 per share in cash.

Key Points: 
  • As previously announced, under the terms of the transaction, ManTech stockholders will receive $96.00 per share in cash.
  • We thank our stockholders for their strong support of this transaction, said ManTech Chairman, Chief Executive Officer and President Kevin M. Phillips.
  • We look forward to completing the transaction with Carlyle to deliver immediate and premium value to our stockholders, stronger outcomes for our customers and more opportunities for our employees.
  • This communication contains certain forward-looking statements concerning ManTech and the proposed transaction between ManTech and Carlyle.

Delic Executive Chairman Matt Stang Named to World Biz Magazine's Top 100 CEOs in Innovation

Retrieved on: 
Wednesday, September 7, 2022
DELC, Phrase, Patient, COVID-19, Reality Sandwiches, CEO, CSE, Research, Legislation, KWC, Time, USD, Person, Health Canada, Education, Multimedia, Creativity, Mergers and acquisitions, Leadership, Company, Compliance, FRA, Failure, Transaction, Regulation, Tripura Merger Agreement, Private Securities Litigation Reform Act, Industry, Growth, Health, Nature, Management, Risk management, Innovation, BC

World Biz Magazine's Top 100 CEOs in Innovation list recognizes individuals who exhibit exceptional leadership and vision while making invaluable contributions to their industries.

Key Points: 
  • World Biz Magazine's Top 100 CEOs in Innovation list recognizes individuals who exhibit exceptional leadership and vision while making invaluable contributions to their industries.
  • VANCOUVER, BC, Sept. 7, 2022 /PRNewswire/ - Delic Holdings Corp ("Delic" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, today celebrated Matt Stang, recently named Executive Chairman of Delic Corp, as one of World Biz Magazine's Top 100 CEOs in Innovation in 2022.
  • "It is an honor to be recognized by World Biz Magazine as one of the foremost innovators in healthcare today.
  • To learn more about Matt Stang's inclusion on World Biz Magazine's Top 100 CEOs in Innovation list, please visit www.worldbizmagazine.net .

Delic Announces Postponement of Meet Delic Conference

Retrieved on: 
Tuesday, September 6, 2022
DELC, Phrase, COVID-19, Reality Sandwiches, CSE, Research, Legislation, Awareness, Time, Heart, Culture, Person, Science, Health Canada, Education, Multimedia, Mergers and acquisitions, Acceleration, Conference, Movement, Company, Compliance, DJ, FRA, Failure, Transaction, Regulation, Tripura Merger Agreement, Private Securities Litigation Reform Act, Ministry of Health & Wellness, Health, Industry, Growth, Nature, Hotel, Nightclub, Risk management, AREA15, BC

Meet Delic will now be held on October 14 and 15, 2023 in Las Vegas

Key Points: 
  • Meet Delic will now be held on October 14 and 15, 2023 in Las Vegas
    VANCOUVER, BC, Sept. 6, 2022 /PRNewswire/ - Delic Holdings Corp ("Delic" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, today announced the postponement of the Meet Delic conference taking place November 5 and 6 at AREA15 in Las Vegas, Nevada.
  • Delic's annual Meet Delic conference has emerged as the world's premier psychedelic wellness experience.
  • The company plans to build upon the success of Meet Delic 2021 when it returns next year to AREA15 in Las Vegas.
  • For more information regarding becoming a sponsor or attending the next Meet Delic Conference, please visit https://meetdelic.com/ .

LAIX Inc. Sets Record Date for Dissemination of Transaction Statement and Plan of Merger for "Going Private" Transaction

Retrieved on: 
Tuesday, September 6, 2022
Cayman Islands, COVID-19, ADS, AI, OTC, Tripura Merger Agreement, Artificial intelligence, Learning, Forward-looking statement, Goal, U.S. Securities and Exchange Commission, OTC Markets Group, Company, Schedule, Terminology, ADSS, Annual report, Private Securities Litigation Reform Act, Growth, Plan, Airline, Bank, Parent, Mergers and acquisitions, PRC

The Plan of Merger is substantially in the form attached as Exhibit A to the Merger Agreement.

Key Points: 
  • The Plan of Merger is substantially in the form attached as Exhibit A to the Merger Agreement.
  • The merger is currently expected to close in October 2022 and is subject to the terms and conditions set forth in the Merger Agreement.
  • LAIX Inc. ("LAIX" or the "Company") is an artificial intelligence (AI) company in China that creates and delivers products and services to popularize English learning.
  • Further information regarding these and other risks is included in the Company's filings with the U.S. Securities and Exchange Commission.

Discovery of Bispecific Antibodies and Immune Checkpoint Inhibitors That Kill Glioblastoma Cells and Melanoma Cells, and Block the Metastasis of Malignant Melanoma Cells to the Lung by Over 90%, Announced by Ocean Biomedical, Inc. and Aesther Healthcare

Retrieved on: 
Tuesday, September 6, 2022
Lung cancer, COVID-19, Human, CEO, Safety, Biomedicine, Research, Antibody, Culture, Lung, NEW, PD-1, Mergers and acquisitions, GLOBE, 100,000, Risk, PD-L1, Metastasis, Patient, Inflammation, University, CTLA4, Cancer, Survival, Ageing, Protein, SEC, Immunology, FDA, Communication, Transaction, Cell death, Tripura Merger Agreement, Secondary research, Lists of diseases, Brain, GBM, Pulmonary fibrosis, NASDAQ, Glioblastoma, Skin cancer, PTEN, Investment, Probability, NSCLC, Neoplasm, Melanoma, Non-small-cell lung carcinoma, Acquisition, Growth, HIV disease progression rates, SPAC, XV, Ix, Mouse, PD, Therapy, Failure, Malaria, Apoptosis, Biology, Forward-looking statement, Medical device, Medical imaging, Vaccine, Pharmaceutical industry, Risk management, CHI3L1, Medicine, R.I

PROVIDENCE, R.I. and NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Ocean Biomedical and Aesther Healthcare Acquisition Corp. (“Aesther”) (NASDAQ: AEHA) announced today the discovery of bispecific antibodies that target Chitinase 3-like-1 and immune checkpoint inhibitors, killing glioblastoma cells and melanoma cells, and blocking the metastasis of malignant melanoma cells to the lung by over 90%. Glioblastoma multiforme (GBM) is a deadly type of brain tumor and 5-year survival is just 8% for those aged 45-54. About 25% of GBM patients are not actively treated due to rapid disease progression. Malignant melanoma, the most serious skin cancer, can metastasize to other organs. Once it has spread to other organs it is difficult to treat. Metastatic melanoma (Stage IV) has 22.5% five year survival. Non-small cell lung cancer (NSCLC) is a major unmet medical need that accounts for 85% of pulmonary malignancies and effects approximately 450,000 individuals. In greater than 50% of affected patients the tumors are diagnosed at advanced stages with metastatic spread that precludes curative surgical resection.

Key Points: 
  • Antibodies that target ICPI such as PD-1, PD-L1 and CTLA4 have been generated which have therapeutic efficacy in NSCLC and other tumors.
  • The impressive ability of our bispecific antibodies to control primary and metastatic lung cancer in murine experimental modeling systems is discussed below.
  • In the coculture system, critical immune regulating cells called T cells were placed in culture with cancer cells.
  • Neither of Ocean Biomedical or Aesther gives any assurance that Ocean Biomedical or Aesther, or the combined company, will achieve its expectations.

CynergisTek Inc. Stockholders Approve Merger Agreement

Retrieved on: 
Wednesday, August 31, 2022
Internet, Consulting, Security, Professional Services, Technology, Security (finance), COVID-19, Securities Exchange Act of 1934, NYSE, Securities Act of 1933, Tripura Merger Agreement, Government, Proxy, LinkedIn, SEC, Organization, Unitary state, U.S. Securities and Exchange Commission, Mergers and acquisitions, Risk management, Privacy, Company, Compliance, Communication, Twitter, Form, Industry

CynergisTek, Inc. (NYSE American: CTEK), (CynergisTek), a leading cybersecurity, privacy, compliance, and IT audit firm helping organizations in highly regulated industries navigate emerging security and privacy issues, today announced that its stockholders have voted to approve the previously announced merger agreement dated May 23, 2022 (Merger Agreement) with Clearwater Compliance LLC (Clearwater), a healthcare focused cybersecurity, compliance, and risk management solutions firm, and approval of the proposed merger contemplated by the Merger Agreement in an all cash transaction that values CynergisTek at approximately $17.7 million (the Merger).

Key Points: 
  • CynergisTek, Inc. (NYSE American: CTEK), (CynergisTek), a leading cybersecurity, privacy, compliance, and IT audit firm helping organizations in highly regulated industries navigate emerging security and privacy issues, today announced that its stockholders have voted to approve the previously announced merger agreement dated May 23, 2022 (Merger Agreement) with Clearwater Compliance LLC (Clearwater), a healthcare focused cybersecurity, compliance, and risk management solutions firm, and approval of the proposed merger contemplated by the Merger Agreement in an all cash transaction that values CynergisTek at approximately $17.7 million (the Merger).
  • CynergisTek today held its virtual special meeting of stockholders (the Special Meeting) to vote on, among other things, the Merger Agreement and proposed Merger with a subsidiary of Clearwater.
  • The first proposal, to adopt the Merger Agreement and approve the Merger, was approved by the affirmative vote of a majority of the outstanding shares of CynergisTek common stock entitled to vote thereon.
  • References herein to terms of the Merger Agreement are subject to, and are qualified by reference to, the full terms of the Merger Agreement, which CynergisTek filed with the SEC on Form 8-K on May 23, 2022.

Sprague Resources LP Announces Amendment to Merger Agreement with Hartree Partners and New Anticipated Closing Timing

Retrieved on: 
Wednesday, August 31, 2022
Securities Exchange Act of 1934, NYSE, Calendar, Speaker of the House of Commons (United Kingdom), Sale, Sprague, SEC, U.S. Securities and Exchange Commission, Goal, Amendment, Mergers and acquisitions, GLOBE, Tripura Merger Agreement, Natural gas, Annual report, Security (finance), Partnership, Hartree

PORTSMOUTH, N.H., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Sprague Resources LP (the Partnership) (NYSE: SRLP) today announced that it has entered into an amendment (the Amendment) to the agreement and plan of merger (the Merger Agreement) with an affiliate of Hartree Partners, LP (Hartree), pursuant to which Hartree will acquire all of the outstanding common units of the Partnership (the Common Units) not already owned by Hartree and its affiliates (the Merger).

Key Points: 
  • PORTSMOUTH, N.H., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Sprague Resources LP (the Partnership) (NYSE: SRLP) today announced that it has entered into an amendment (the Amendment) to the agreement and plan of merger (the Merger Agreement) with an affiliate of Hartree Partners, LP (Hartree), pursuant to which Hartree will acquire all of the outstanding common units of the Partnership (the Common Units) not already owned by Hartree and its affiliates (the Merger).
  • Following execution of the Amendment, the Partnership expects that the Merger will close in the fourth quarter of 2022.
  • Sprague Resources LP is a master limited partnership engaged in the purchase, storage, distribution and sale of refined petroleum products and natural gas.
  • Sprague undertakes no obligation and does not intend to update any forward-looking statements to reflect new information or future events.

North Mountain Merger Corp. and Corcentric Mutually Agree to Terminate Merger Agreement

Retrieved on: 
Monday, August 29, 2022
Security (finance), CEO, SPAC, Prospectus, Securities Exchange Act of 1934, Securities Act of 1933, Nasdaq, Tripura Merger Agreement, NASDAQ, Solution, Risk, Person, IPO, SEC, U.S. Securities and Exchange Commission, Mergers and acquisitions, NMMC, Commerce, GLOBE, Company, Acquisition, Growth, Industry, Forward-looking statement, Online shopping, Corcentric, LLC

NEW YORK and CHERRY HILL, N.J., Aug. 29, 2022 (GLOBE NEWSWIRE) -- North Mountain Merger Corp. (NASDAQ: NMMC) (North Mountain or Company), a publicly traded special purpose acquisition company, and Corcentric (Corcentric), a leading global provider of payments, procurement, accounts payable, and accounts receivable solutions to enterprise and middle-market companies, announced today that they have mutually agreed to terminate their previously announced agreement and plan of merger (the Merger Agreement), effective immediately.

Key Points: 
  • NEW YORK and CHERRY HILL, N.J., Aug. 29, 2022 (GLOBE NEWSWIRE) -- North Mountain Merger Corp. (NASDAQ: NMMC) (North Mountain or Company), a publicly traded special purpose acquisition company, and Corcentric (Corcentric), a leading global provider of payments, procurement, accounts payable, and accounts receivable solutions to enterprise and middle-market companies, announced today that they have mutually agreed to terminate their previously announced agreement and plan of merger (the Merger Agreement), effective immediately.
  • The proposed merger, initially announced in December 2021, was conditioned on the satisfaction of certain closing conditions within the timeframe outlined by the Merger Agreement.
  • Neither party will be required to pay the other a termination fee as a result of the mutual decision to terminate the Merger Agreement.
  • About North Mountain Merger Corp.
    North Mountain Merger Corp. is a special purpose acquisition company (or SPAC) which raised $132.25 million in its IPO in September 2020 and is listed on the Nasdaq Capital Market (NASDAQ: NMMC).

ALPINE ACQUISITION CORPORATION ANNOUNCES INTENTION TO EXTEND DEADLINE TO CONSUMMATE BUSINESS COMBINATION

Retrieved on: 
Monday, August 29, 2022
Prospectus, Tripura Merger Agreement, Register, NASDAQ, TBC, PHF, Sale, Ownership, Person, Proxy, Sponsor, Forward-looking statement, SEC, Reading, Special, GLOBE, Company, Failure, Risk, Acquisition, Crowne Plaza, Plan, Extension, Registration statement, Risk management, Security (finance), Property management, Alpine

FOUNTAIN HILLS, AZ, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Alpine Acquisition Corporation (NASDAQ: REVE) (Alpine or the Company) announced today that its sponsor, Alpine Acquisition Sponsor LLC (the Sponsor), requested that the Company extend the date by which it has to consummate a business combination fromSeptember 2, 2022 toDecember 2, 2022(the Extension).

Key Points: 
  • FOUNTAIN HILLS, AZ, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Alpine Acquisition Corporation (NASDAQ: REVE) (Alpine or the Company) announced today that its sponsor, Alpine Acquisition Sponsor LLC (the Sponsor), requested that the Company extend the date by which it has to consummate a business combination fromSeptember 2, 2022 toDecember 2, 2022(the Extension).
  • Alpine is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities.
  • In connection with the proposed business combination, Alpine has filed a registration statement on FormS-4(the Registration Statement) that includes a proxy statement and prospectus of Alpine.
  • Alpine may also file other documents regarding the proposed business combination with the SEC.

HBT Financial, Inc. Expands Illinois Footprint Through Merger with Town and Country Financial Corporation

Retrieved on: 
Tuesday, August 23, 2022
CEO, Prospectus, Securities Act of 1933, RISKS, Small Business Administration, U.S. Securities and Exchange Commission, Organization, GLOBE, Company, Trust Company, Risk, WHEN, Tripura Merger Agreement, Small business, Time, AS, Sale, Heartland Bank, Keefe, Bruyette & Woods, AND, SEC, Housing, History, THE, Bank, COUNTRY, Registration statement, Security (finance), OTC, Trust, Securities Exchange Act of 1934, NASDAQ, Investment, TIME, Town and Country, News, Private Securities Litigation Reform Act, EPS, Register, Person, St. Louis Metro-East Airport, Form, HBT, Real estate, Cryptocurrency, Financial adviser, Central Illinois, Country

BLOOMINGTON, Ill. and SPRINGFIELD, Ill., Aug. 23, 2022 (GLOBE NEWSWIRE) -- HBT Financial, Inc. (NASDAQ: HBT) (HBT or HBT Financial), the holding company for Heartland Bank and Trust Company (Heartland Bank), and Town and Country Financial Corporation (OTC: TWCF) (Town and Country), the holding company for Town and Country Bank, today jointly announced the signing of a definitive agreement pursuant to which HBT Financial will merge with Town and Country Financial Corporation and Town and Country Bank.

Key Points: 
  • BLOOMINGTON, Ill. and SPRINGFIELD, Ill., Aug. 23, 2022 (GLOBE NEWSWIRE) -- HBT Financial, Inc. (NASDAQ: HBT) (HBT or HBT Financial), the holding company for Heartland Bank and Trust Company (Heartland Bank), and Town and Country Financial Corporation (OTC: TWCF) (Town and Country), the holding company for Town and Country Bank, today jointly announced the signing of a definitive agreement pursuant to which HBT Financial will merge with Town and Country Financial Corporation and Town and Country Bank.
  • Fred Drake, Chairman and CEO of HBT Financial, said, We are very pleased to announce our merger with Town and Country Financial Corporation, which is a highly compatible franchise that we have respected and admired for a long time.
  • Micah Bartlett, President and CEO of Town and Country Financial Corporation, said, The Town and Country team is proud to have created a high-quality, high-performing financial services company.
  • Town and Country Financial Corporation, headquartered in Springfield, Illinois, operates as the parent holding company for Town and Country Bank including the Bank's subsidiary, Town and Country Banc Mortgage Services, Inc. (TCBMSI), with locations throughout the central, west-central, and metro-east areas of Illinois.